The FDA has cleared the research organization's investigational new drug application, allowing it to start clinical tests of the experimental treatment DT2-SCT.

People living with HIV may also have to manage other health conditions like cardiovascular disease, type 2 diabetes, ...

The president of the union representing workers at the CISSS de Laval (FSSS–CSN) said she was “insulted and dumbfounded” by ...

The rise in type 2 diabetes cases globally presents opportunities for growth in the market for GLP-1 drugs like Ozempic and ...

Diabetes is the eighth leading cause of death in the US and can lead to other conditions, including kidney failure, ...

Fourteen percent of the world's people -- more than 800 million -- now have diabetes, a doubling of the global rate ...

More than 800 million adults have diabetes worldwide – almost twice as many as previous estimates have suggested – and more ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million—over four ...

2 There are currently no treatments approved for MASLD, formerly known as nonalcoholic fatty liver disease. Instead, ...

People living with type 2 diabetes face several significant health challenges. The condition, which affects more than 10% of ...

The findings offer promising support for progressing ADPO-002NP treatment to first-in-human Phase I clinical trials. Adipo ...